BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10403304)

  • 1. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.
    Seidman JD; Wasserman CS; Aye LM; MacKoul PJ; O'Leary TJ
    Am J Surg Pathol; 1999 Jul; 23(7):809-14. PubMed ID: 10403304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine müllerian adenosarcoma with sarcomatous overgrowth and lung metastasis in a 25-year-old woman.
    Choi YJ; Jung MH; Park YK; Lee BY; Huh CY
    Eur J Gynaecol Oncol; 2011; 32(1):91-4. PubMed ID: 21446335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mullerian adenosarcomas of the uterine cervix with sarcomatous overgrowth.
    Kudela E; Nachajova M; Balharek T; Gabonova E; Danko J
    Curr Probl Cancer; 2019 Aug; 43(4):371-376. PubMed ID: 30522776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
    Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
    Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis-related clinicopathologic characteristics of FIGO stage Ⅰ Müllerian adenosarcoma of uterus].
    Wang Y; Liu AJ; Chen X; Song X
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):334-338. PubMed ID: 29783798
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-radiation Mullerian adenosarcoma with sarcomatous overgrowth: rare presentation of an uncommon malignancy.
    Mubeen A; Shahid M; Makary R
    Pathologica; 2020 Dec; 112(4):219-223. PubMed ID: 33393526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Müllerian adenosarcoma of the uterus: report of a case with imprint cytology.
    Takeshima N; Tabata T; Nishida H; Arai Y; Tsuzuku M; Hirai Y; Yamauchi K; Hasumi K
    Acta Cytol; 2001; 45(4):613-6. PubMed ID: 11480728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mullerian adenosarcoma (heterologous) of uterine cervix with sarcomatous overgrowth: A case report with review of the literature.
    Mohapatra D; Mohanty P; Biswal R
    Indian J Pathol Microbiol; 2019; 62(1):139-141. PubMed ID: 30706880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
    Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
    Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
    BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low grade Mullerian adenosarcoma of pouch of Douglas recurring as bilateral ovarian high grade Mullerian adenosarcoma with rhabdomyosarcomatous overgrowth after 11 years.
    Kumar S; Raza M; Tariq MU
    J Pak Med Assoc; 2018 Aug; 68(8):1263-1266. PubMed ID: 30108400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
    Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
    Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature.
    Eichhorn JH; Young RH; Clement PB; Scully RE
    Am J Surg Pathol; 2002 Oct; 26(10):1243-58. PubMed ID: 12360039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Müllerian adenosarcoma with sarcomatous overgrowth of the cervix: unusual large polypoid mass.
    Comunoğlu N; Comunoğlu C; Başsüllü N; Somunkiran A; Calay Z
    Ups J Med Sci; 2007; 112(1):67-72. PubMed ID: 17578809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late recurrence of uterine Mullerian adenosarcoma as heterologous sarcoma: Three recurrences in 8 months increasing in number and grade of sarcomatous components.
    Taçkin S; Bozaci EA; Sönmezer M; Ekinci C; Ortaç F
    Gynecol Oncol; 2006 Apr; 101(1):179-82. PubMed ID: 16325895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine Adenosarcoma: a Review.
    Nathenson MJ; Ravi V; Fleming N; Wang WL; Conley A
    Curr Oncol Rep; 2016 Nov; 18(11):68. PubMed ID: 27718181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.